Discounted Cash Flow Rating
Strong Buy
Return on Equity Rating
Strong Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Strong Sell
Analyst Rating
Neutral
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Neutral
Standard Deviation
Strong Sell
Williams %R
Strong Buy
Average Directional Index
Strong Sell
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Athira Pharma, Inc. Common Stock (ATHA)
Biological Products, (no Disgnostic Substances)
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.
18706 NORTH CREEK PARKWAY, SUITE 104
BOTHELL, WA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
09/18/2020
Market Cap
115,702,594
Shares Outstanding
38,060,000
Weighted SO
38,054,583
Total Employees
N/A
Upcoming Earnings
08/08/2024
Similar Tickers
Beta
2.9120
Last Div
0.0000
Range
1.33-4.298
Chg
0.0200
Avg Vol
122485
Mkt Cap
115702594
Exch
NASDAQ
Country
US
Phone
425 620 8501
DCF Diff
0.6492
DCF
2.3408
Div Yield
0.0000
P/S
69.8687
EV Multiple
-0.2893
P/FV
1.3862
Div Yield %
0.0000
P/E
-1.0183
PEG
0.0302
Payout
0.0000
Current Ratio
3.9664
Quick Ratio
3.9664
Cash Ratio
3.0556
DSO
358.8285
DIO
0.0000
Op Cycle
358.8285
DPO
178.1860
CCC
180.6425
Gross Margin
0.4124
Op Margin
-73.3086
Pretax Margin
-68.5091
Net Margin
-68.5091
Eff Tax Rate
-0.0189
ROA
-1.0198
ROE
-0.9553
ROCE
-1.4392
NI/EBT
1.0000
EBT/EBIT
0.9345
EBIT/Rev
-73.3086
Debt Ratio
0.0126
D/E
0.0169
LT Debt/Cap
0.0120
Total Debt/Cap
0.0166
Int Coverage
-62.2559
CF/Debt
-69.9439
Equity Multi
1.3350
Rec Turnover
1.0172
Pay Turnover
2.0484
Inv Turnover
0.0000
FA Turnover
0.4287
Asset Turnover
0.0149
OCF/Share
-2.5641
FCF/Share
-2.5658
Cash/Share
2.6092
OCF/Sales
-59.4269
FCF/OCF
1.0006
CF Coverage
-69.9439
ST Coverage
-251.6905
CapEx Coverage
-1562.0794
Div&CapEx Cov
-1562.0794
P/BV
1.3862
P/B
1.3862
P/S
69.8687
P/E
-1.0183
P/FCF
-1.1750
P/OCF
-1.1739
P/CF
-1.1739
PEG
0.0302
P/S
69.8687
EV Multiple
-0.2893
P/FV
1.3862
DPS
0.0000
Latest Headlines (EST)
No Headlines Found